NR4A1 and epilepsy: Using a data-driven, supervised fusion approach, we discovered that higher NR4A1 levels in TLE patients may be related to functional and structural impairment in thalamus, putamen, temporal pole, and cerebellum, which were further linked with earlier age of disease onset, and poorer executive function in epilepsy patients.